About this trial
Chronic pain is common complication of surgery procedures. Rates of mortalits is getting lower in cardiac surgery. This situation has brought us to focus morbidity and long term life quality. Previous study show that chronic pain after cardiac surgery is experienced 11-40% patient. Multifactorial causes play a role in chronic pain etiology. The aim of our study is to determine the causes of chronic pain in patients who underwent sternotomy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Between the ages of 18-80
BMI 18-35 kg/m2
ASA (American Society of Anesthesiologists) Scoring I-II-III
Elective open coronary artery bypass graft surgery
Disqualifiers
Patients under 18 and over 80 years of age
Patients who do not want to participate in the study
Patients with advanced organ failure (liver failure, renal failure)
Patients with chronic pain or chronic opioid use
Trial population
Patients in the ASA I-II-III risk group, between the ages of 18-80 years, with a BMI between 18-35 kg/m2, who will undergo elective open coronary artery bypass graft surgery, who will undergo elective open heart valve surgery, who will undergo general anesthesia, and who will undergo sternotomy will be included in the study.
Trial design
Cohort
Prospective
Treatments tested in this trial
Open cardiac surgery with sternotomy
Procedure/SurgeryFactors affecting the occurrence of chronic pain in patients undergoing open cardiac surgery with sternotomy will be investigated.
Treatment groups
Trial outcomes
Primary outcomes
Self-leeds assessment of neuropathic symptoms and sign findings in 3rd months.
Patients' self-Leeds assessment of neuropathic symptoms and sign (S-LANSS) findings will be evaluated in the 3rd postoperative month. Patients with an S-LANSS score of 12 and above will be diagnosed with chronic neuropathic pain.
Secondary outcomes
Self-leeds assessment of neuropathic symptoms and sign findings at 6th months
Patients' self-Leeds assessment of neuropathic symptoms and sign (S-LANSS) findings will be evaluated in the 3rd postoperative month. Patients with an S-LANSS score of 12 and above will be diagnosed with chronic neuropathic pain.
Short Form 12 scores in the 3rd month.
Short Form 12 scores will be evaluated in the 3rd month to evaluate the quality of life of the patients.
Short Form 12 scores in the 6th month.
Short Form 12 scores will be evaluated in the 6th month to evaluate the quality of life of the patients.
Acute pain score
Pain will be assessed at rest and while coughing using the visual analog scale on a scale from 0 (no pain) to 10 (worst pain). Pain assessment will be made in 1, 2, 12, 24 hour after extubation in the postoperative period.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.